FDA Adverse Event
Death
Summary report: N
MAQUET - AXILLO-BIFEMORAL HEMOGARD KNITTED
MDR report key: 17490568
·
Received August 9, 2023
Report
- Report Number
- MW5122781
- Event Type
- Death
- Date Received
- August 9, 2023
- Date of Event
- July 21, 2023
- Report Date
- August 7, 2023
- Manufacturer
- MAQUET" GENTINGE GROUP / INTERVASCULAR, SAS
- Product Code
- MAL
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Occupation
- RISK MANAGER
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
UNDERWENT HEART CAUTERIZATION FOR POSSIBLE INTERVENTION AND INSERTION OF IMPELLA AND ECMO DUE TO CARDIOGENIC SHOCK. DURING INSERTION OF BIFEMORAL GRAPH VIA CUTDOWN TO LEFT ARTERY, UNCONTROLLED BLEEDING. BLEEDING AT GRAPH SITE DESCRIBED AS "SPRAYING/ APPEARING AS A SPRINKLER". ESTIMATED BLOOD LOSS >4L. UNABLE TO CONTROL BLEEDING, PATIENT EXPIRED. THERAPEUTIC RANGE FOR HEPARIN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2014057 | MAQUET - AXILLO-BIFEMORAL HEMOGARD KNITTED | GRAFT, VASCULAR, SYNTHETIC/BIOLOGIC COMPOSITE | MAL | MAQUET" GENTINGE GROUP / INTERVASCULAR, SAS | WATER PERM <5ML/CM2/MIN | 22K06 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 58 YR | Female | Death |